Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. latin america
  4. solid tumor
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads
Videos

Refine by
Locations
Back to All Locations

  • Latin America
  • Antigua & Barbuda
  • Argentina
  • Aruba
  • Bahamas
  • Barbados
  • Belize
  • Bolivia
  • Brazil
  • Cayman Islands
  • Chile
  • Colombia
  • Costa Rica
  • Cuba
  • Dominica
  • Dominican Republic
  • Ecuador
  • El Salvador
  • Grenada
  • Guatemala
  • Guyana
  • Haiti
  • Honduras
  • Jamaica
  • Mexico
  • Netherlands Antilles
  • Nicaragua
  • Panama
  • Paraguay
  • Peru
  • Puerto Rico
  • St. Kitts & Nevis
  • St. Lucia
  • St. Vincent & The Grenadines
  • Suriname
  • Trinidad
  • Uruguay
  • Venezuela
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
  • Laboratory
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
  • Monitoring and Testing
  • Environmental
  • Health and Safety
Employees

  • 101-1000
  • Over 1000

Solid Tumor Suppliers Serving Latin America

105 companies found
Serving Latin AmericaNear Latin America

Biozol GmbH

Biozol GmbH

based inEching,, GERMANY
BIOZOL - World of Science distribution service. We provide you more than 25 Million products of more than 260 partner companies around the world. For our customers we overcome national borders, customs and import regulations. So, you receive for ...
Immunoselect Antifading Mounting Medium DAPI

Immunoselect Antifading Mounting Medium DAPI

contains DAPI nuclear staining dye, fluorescence mounting medium, no background autofluorescence, slowly hardening over weeks, strong reduction of photobleaching, viscous fluid, water-based ...
CONTACT SUPPLIER

MorphoSys AG

MorphoSys AG

based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
CONTACT SUPPLIER

AbelZeta Inc.

AbelZeta Inc.

based inRockville, MARYLAND (USA)
Since the treatment of our first oncology patient in 2015, AbelZeta has been able to build best-in-class and best-in-disease potential pipeline, leading to the licensing of two CD20-directed autologous CAR-Ts to Janssen Biotech in 2023. Our goal is ...
Model C-CAR031 - Solid Tumors

Model C-CAR031 - Solid Tumors

PRODUCT: C-CAR031. INDICATION: HCC. PLATFORM: CAR-T. PRECLINICAL: GPC3. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
CONTACT SUPPLIER

Nkarta, Inc.

Nkarta, Inc.

based inSouth San Francisco, CALIFORNIA (USA)
We are dedicated to realizing the potential of natural killer (NK) cells for the treatment of cancer. Our proprietary technology is designed to harness the power of these important pathogen-fighting immune cells and is uniquely capable of enhancing ...
Nkarta - Model NKG2D - NKX101 - Activating Receptor

Nkarta - Model NKG2D - NKX101 - Activating Receptor

OX40 costimulatory domain, CD3ζ signaling moiety, membrane bound ...
CONTACT SUPPLIER

Olink Proteomics

Olink Proteomics

based inUppsala, SWEDEN
Olink Proteomics is a Swedish company dedicated to innovation, quality, rigor and transparency, providing outstanding products and services for human protein biomarker discovery. Our groundbreaking Olink panels for precision proteomics help ...
Olink Explore - Model 384 -II - Oncology & Oncology Protein Biomarker Panel

Olink Explore - Model 384 -II - Oncology & Oncology Protein Biomarker Panel

The most comprehensive, high-performance protein biomarker panels available for oncology studies. The flexibility and scalability of our Olink® Explore platform can be utilized either to screen our entire library of 3072 assays, or in ...
CONTACT SUPPLIER

LIXTE Biotechnology Holdings, Inc.

LIXTE Biotechnology Holdings, Inc.

based inPasadena, CALIFORNIA (USA)
LIXTE is a drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead clinical compound. LB-100 has potential widespread use as an anti-cancer agent when used alone and in ...
Model LB-100 - Hematologic and Solid Tumor Cancers

Model LB-100 - Hematologic and Solid Tumor Cancers

Pre-clinical studies showed that LB-100 alone inhibits a spectrum of human cancers but when combined with standard cytotoxic drugs and/or radiation, LB-100 potentiates their effectiveness against hematologic and solid ...
CONTACT SUPPLIER

Celluris

Celluris

based inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is considered less aggressive than ...
CONTACT SUPPLIER

HEALIOS K.K.

HEALIOS K.K.

based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
iPSC - Regenerative Medicine

iPSC - Regenerative Medicine

Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and grow indefinitely (proliferation). ...
CONTACT SUPPLIER

Sutro Biopharma Inc.

Sutro Biopharma Inc.

based inSouth San Francisco, CALIFORNIA (USA)
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific ...
CONTACT SUPPLIER

SystImmune Inc.

SystImmune Inc.

based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-039 - Guidance and Navigation Control (GNC) Molecules

Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
CONTACT SUPPLIER

MtoZ Biolabs

MtoZ Biolabs

based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
CONTACT SUPPLIER

BetaGlue Technologies SpA

BetaGlue Technologies SpA

based inMilano, ITALY
BetaGlue Technologies can deliver a localized amount of energy via a simple, intra-operative, internal radiotherapy platform engineered to achieve maximum efficacy and much improved safety for the patients. A new anti-tumoral compound based on 90Y ...
BetaGlue - Anti-Tumoral Compound

BetaGlue - Anti-Tumoral Compound

Surgery is the standard of care for resectable solid tumors. Loco-regional approaches, in combination with chemotherapy and/or radiotherapy, are standard therapy in the following ...
CONTACT SUPPLIER

NeoTherma Oncology

NeoTherma Oncology

based inWichita, KANSAS (USA)
Neotherma Oncology is led by experienced healthcare executives who are working toward the dream of more effective treatments for cancer. NeoTherma Oncology is developing a groundbreaking type of radio frequency (RF) thermal treatment for deep solid ...
NeoTherma VectRx - Clinical Stage Medical Device

NeoTherma VectRx - Clinical Stage Medical Device

NeoTherma Oncology is a clinical stage medical device company developing a proprietary Thermal Treatment (VectRx) system for deep solid tumors. Our technology is based on applying a safe, non-invasive, non-ionizing ...
CONTACT SUPPLIER

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc.

based inBoston, MASSACHUSETTS (USA)
AVEO is an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for cancer patients. AVEO™s strategy is to focus its resources toward development and commercialization of its product candidates in ...
AVEO - Model AV-203 - ErbB3 Signaling Inhibitory Antibody

AVEO - Model AV-203 - ErbB3 Signaling Inhibitory Antibody

AV-203 (CAN017) is a clinical-stage ErbB3 (HER3) inhibitory antibody candidate designed to inhibit both ligand-dependent and ligand-independent ErbB3 signaling. ErbB3 is a receptor that is typically expressed in many human cancers, and AV-203 has ...
CONTACT SUPPLIER

Jubilant Therapeutics Inc.

Jubilant Therapeutics Inc.

based inBedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Model LSD1/HDAC6 - Cancer Stem Cell

Model LSD1/HDAC6 - Cancer Stem Cell

Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
CONTACT SUPPLIER

Exosome Diagnostics, Inc.

Exosome Diagnostics, Inc.

based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
CONTACT SUPPLIER

Ibio, Inc.

Ibio, Inc.

based inBryan, TEXAS (USA)
At iBio, we are using our RubrYc® Discovery Platform to tackle complex and challenging drug targets, with the goal of developing safer and more effective immunotherapies for difficult-to-treat cancers. We envision a world where drug discovery is ...
IBIO - Model 101 - Immuno Oncology Therapeutics

IBIO - Model 101 - Immuno Oncology Therapeutics

Advances in the field of immuno-oncology have led to new and better treatment outcomes for a range of cancers, and particularly, blood cancers. However, even with the advent of checkpoint inhibitors as immunotherapies for solid ...
CONTACT SUPPLIER

Senti Biosciences

Senti Biosciences

based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Model SENTI-301 - Multi-Armed Allogeneic CAR-NK Cell Therapy for HCC

Model SENTI-301 - Multi-Armed Allogeneic CAR-NK Cell Therapy for HCC

The product profile of SENTI-301 has the potential to promote expansion and persistence of NK cells, and activate and recruit the body’s own immune cells into the solid tumor microenvironment for ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo - Off-the-shelf Adoptive Cell Therapy

ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
CONTACT SUPPLIER

SOPHiA Genetics

SOPHiA Genetics

based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries.  Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
SOPHiA DDM - For Liquid Biopsy

SOPHiA DDM - For Liquid Biopsy

Pioneering Innovation, Streamlining Adoption: We are pushing the boundaries of today’s liquid biopsy capabilities. Bring liquid biopsy to your lab with our streamlined DNA-only NGS workflow, taking you from cell-free DNA sample to ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT